top of page
Subtle Shapes Transparent_edited_edited.png


Stem Cell Therapy 


We have developed a disruptive biotech nanotechnology which creates remote-controlled stem cells - technology which is at the cusp of beginning Phase 1 clinical trials after successful pre-clinical trials.

The technology answers the fundamental problem of selective stem cell differentiation. Stem cells in their current form are placed into a patient with the hope that they create the desired tissue purely based on their environment - which has a high failure rate. Through nanotechnology, we developed Remote-Controlled Stem Cell Technology, which allows clinicians to select the type of tissue they would like to create in situ. We are focussing first on spinal fusion.

The Problem

To date, the true potential of stem cells in regenerative medicine has been unattainable due to limited control of the type of tissue these cells transform into. This lack of control renders these therapies expensive and unscalable in the broader market.

The Solution

To achieve greater control of target cells to allow for precise differentiation depending on the specific treatment required by the patient.

Our Approach

Following a biologic-device combination product pathway, MICA technology uses magnetic nanoparticles which bind to specific sites on the patient’s cells.

Subtle Shapes Transparent_edited_edited.png

Remote-Controlled Stem Cell Therapy is our opportunity to revolutionise regenerative medicine. True to this statement, it has a world of possible uses across numerous therapy areas. See below for a snapshot of what this technology means for some of them!

Spinal Fusion

MICA Cell Therapy can be used as a standalone solution to the fusion of vertebrae in situ, turning an invasive and risky surgical procedure into a superficial injection, or in conjunction with existing spinal cages to aid in their effectiveness.

Orthopaedic Device Fixation

MICA technology could be used as a fixation method of orthopaedic implants, such as hip replacement devices, in patients with low bone density.

Tendon Repair

Biological in situ repair of tendons is possible using MICA Cell Therapy - removing, or reducing, the need for surgical tendon repair or transplant.

Craniomaxillofacial Repair

Notoriously difficult, craniomaxillofacial repair can be aided using the MICA technology.

Subtle Shapes Transparent_edited_edited.png

Ready To Find Out More?

We are on hand to provide you with additional material and can schedule a live demonstration with a member of our R&D team. 

bottom of page